Rigel Pharmaceuticals Inc (RIGL)
Rigel Announces Availability of VEPPANU™(vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
Rigel Announces Availability of VEPPANU™(vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Genpact Recognized as a Leader in Financial Crime Compliance by HFS Research
Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
Valvoline Announces Commencement of Senior Notes Offering
Eckrich® Named Official Smoked Sausage and Deli Meat Partner of the Big Ten Conference
Media Advisory: Neogenyx Fuels and Adams Land & Cattle to Break Ground on Agricultural Renewable Natural Gas Facility in Central Nebraska
Financial Statements and Related Announcement: Half Yearly Results
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results